Tracking OPRX? Get live short interest, options flow, and signals on ORTEX.Sign up free →

OptimizeRx Corporation (OPRX) short interest & options flow

NASDAQ

OptimizeRx faces one of its sharpest analyst repricing cycles in months, with three separate target cuts landing on May 13 — the same day Q1 results were digested. The Street moved quickly after the print. Stifel maintained its Buy but pulled its target from $17 to $14. B. Riley Securities also held Buy, trimming from $11 to $10. Stephens & Co. stayed at Equal-Weight and cut from…

$8.74+2.82% 1d+6.33% 1w+19.89% 1mClose: 19 Oct 2026

Short interest % of float
Cost to borrow: Low and dropping
Availability
Put / call ratio

Market cap: $164M
Next earnings: 11 Nov 2026

See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 20 Oct 2026

OPRX news and analysis

RSS

No long-form analysis yet for OPRX. Pulse alerts and the live data picture are available on ORTEX.

Open OPRX on ORTEX →

Want the live picture for OPRX?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for OPRX — free to start on ORTEX.